You are here: Industry Insights > leukaemia

News List

Genetic fault reduces the effectiveness of leukaemia treatment europeanpharmaceuticalreview
September 28, 2017
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment…
US regulators wave through Pfizer’s leukaemia drug pharmatimes
August 21, 2017
The US Food and Drug Administration has approved Pfizer’s Besponsa, the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
Elsalys Biotech and DKFZ collaborate to develop ELB021 in B-Cell leukaemia pharmaceutical-technology
July 21, 2017
Elsalys Biotech has entered a preclinical collaboration with German cancer research institute DKFZ to initiate the development of ELB021 in B-Cell leukaemia, under European Union (EU) sponsored programme Eurostars.
New Pfizer EU approval offers first treatment option for leukaemia subtype pharmafile
July 04, 2017
Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy...
Discovery of predictive protein signature births new leukaemia treatment hopes pharmafile
April 14, 2017
Researchers have discovered a protein signature which has proven to be highly predictive of leukaemia and has given rise to hopes to new, novel treatments for the disease.
Jazz Pharmaceuticals submits FDA application for leukaemia treatment europeanpharmaceuticalreview
April 10, 2017
Jazz Pharmaceuticals completed a rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Vyxeos (cytarabine and daunorubicin) liposome for injection.
Leukaemia CARE’s research finds inequalities in cancer care for elderly patients pharmaceutical-technology
March 28, 2017
UK charity Leukaemia CARE has conducted new research into the lives of older people living with blood cancers and revealed inequalities in cancer care for elderly patients compared with ...
Study links immune system genetic variants to development of leukaemia pharmaceutical-technology
February 08, 2017
A new study has found that people inheriting genetic variants affecting the function of their immune system are at risk of developing chronic lymphocytic leukaemia (CLL).

Previous page 1 2 3 Next page